COMMUNIQUÉS West-GlobeNewswire

BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises
03/06/2019
Santa Monica, CA, June 03, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Annual General Meeting Results and Statement
03/06/2019
Acacia Pharma Group plc Annual General Meeting Results and Statement Cambridge, UK and Indianapolis, US – 3 June 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) announces that all [...]
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness
03/06/2019
GAITHERSBURG, Md., June 03, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract award by the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. [...]
LHC Group announces finalization of purchase agreement and joint venture partnership in New Jersey
03/06/2019
LAFAYETTE, La., June 03, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) and AtlantiCare – A Member of Geisinger have finalized a previously announced joint venture (JV) agreement and purchase that includes home [...]
RadNet, Inc. to Present at the Jefferies 2019 Healthcare Conference on June 7, 2019
03/06/2019
LOS ANGELES, June 03, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
US FDA Review for SCENESSE® Extended by Three Months
03/06/2019
The FDA sets new goal date of 6 October 2019 to complete review and issue risk-benefit decision MELBOURNE, Australia, June 03, 2019 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today published that the US Food and [...]
Arrayit Corporation Signs In-Network Allergy Testing Services Agreement with a Major California-Based Health Benefits Company
03/06/2019
Sunnyvale, June 03, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has entered into an in-network healthcare provider agreement with a major health benefits [...]
Biohit Plc - Managers' transactions - Söderström
03/06/2019
Person subject to the notification requirement Name: Söderström, Daniela Position: Other senior manager Issuer: Biohit Plc LEI: 74370089ATTSNBXJVT29 Notification type: INITIAL NOTIFICATION Reference number: [...]
Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
03/06/2019
Tartu (Estonia) and Plzen (Czech Republic) June 3, 2019 - Icosagen Cell Factory OÜ, a rapidly growing Estonian biotechnology company focusing on protein production and in vivo antibody discovery, and AbCheck s.r.o., a [...]
Oncology Venture receives response from the FDA to the IND-application and proposed pivotal study for LiPlaCis
03/06/2019
Press release Hoersholm, Denmark and Cambridge, MA, US, June 3, 2019. – Oncology Venture A/S (“OV” or “the Company”) today announced that the FDA has given its initial response to the Company’s IND application and [...]
New cigarette filters block up to 60% of harmful substances thanks to Bio-on biopolymers
03/06/2019
Bio-on has patented a new material following research conducted over the last 2 years by CNS laboratories in Italy and Clarkson University in New York state. The new product, a natural and biodegradable polymeric liquid [...]
Grâce aux bio-polymères créés par Bio-on, les filtres de cigarettes sont en mesure de bloquer jusqu’à 60% des substances nocives
03/06/2019
Une nouvelle matière, issue des recherches réalisées au cours des 2 dernières années dans les laboratoires de CNS, en Italie, et par l’université de Clarkson, dans l’État de New York, a été brevetée par Bio-on. Le [...]
Vical and Brickell Announce Merger Agreement
03/06/2019
Combined Company Well-Capitalized with Approximately $35 Million in Cash and up to $25 Million in Near-Term R&D Funding Pivotal Phase 3 Clinical Trials for Brickell’s Lead Product Candidate, Sofpironium Bromide, in [...]
DBV Technologies to Attend Upcoming Investor Conferences
03/06/2019
Montrouge, France, June 3, 2019 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs
03/06/2019
Montrouge, France, le 3 juin (7H30 CET), 2019 DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs DBV Technologies (Euronext: DBV – ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une [...]
Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials
03/06/2019
Primary analysis of investigational capmatinib (INC280) in the GEOMETRY mono-1 study demonstrates promising efficacy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring MET exon- [...]
Basilea reports publication of clinical data for anticancer drug candidates BAL101553 in glioblastoma and derazantinib in intrahepatic cholangiocarcinoma at ASCO meeting
03/06/2019
Basel, Switzerland, June 3, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today the phase 1 data from an ongoing study with the oral formulation of its novel tumor checkpoint controller, BAL101553, in brain [...]
Xolair® (omalizumab) significantly reduced nasal polyps and congestion symptoms in adults with chronic rhinosinusitis with nasal polyps in two phase III studies
03/06/2019
In the phase III POLYP 1 and POLYP 2 studies, omalizumab met both co-primary endpoints and key secondary endpoints in adults with chronic rhinosinusitis with nasal polyps (CRSwNP) with inadequate response to intranasal [...]
Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
03/06/2019
Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Roche data from 17 breast cancer abstracts presented at this year’s meeting An overall [...]

Pages